| J9271 | Injection, pembrolizumab, 1 mg | 11,400 | $40 | $490.2K |
| J0897 | Injection, denosumab, 1 mg | 10,620 | $20 | $191.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 720 | $90 | $64.6K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 40 | $1,130 | $49.9K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 13,520 | $1 | $27K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 280 | $90 | $26.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $130 | $14.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 190 | $50 | $9.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 60 | $150 | $8.2K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 420 | $10 | $4.6K |